Subclinical hyperthyroidism: clinical features and treatment options.

Area of Science:

• Endocrinology
• Thyroidology
• Internal Medicine

Background:

• Subclinical hyperthyroidism is a prevalent endocrine disorder.
• Common causes include excessive levothyroxine (L-T4) therapy and hormone over-replacement in hypothyroidism.
• It presents with symptoms mimicking adrenergic overactivity.

Purpose of the Study:

• To review the clinical significance of subclinical hyperthyroidism.
• To highlight its impact on quality of life and organ systems.
• To emphasize the potential for reversibility and prevention.

Main Methods:

• Literature review of studies on subclinical hyperthyroidism.
• Analysis of effects on quality of life, cardiovascular system, and bone metabolism.
• Synthesis of evidence regarding clinical manifestations and outcomes.

Main Results:

• Subclinical hyperthyroidism diminishes quality of life (psycho-somatic well-being).
• It is associated with cardiovascular changes: increased heart rate, arrhythmias, left ventricular mass, and impaired diastolic/systolic function.
• Accelerated osteoporosis and increased fracture risk, especially in postmenopausal women, are noted.

Conclusions:

• Subclinical hyperthyroidism has significant detrimental effects on cardiovascular health and bone metabolism.
• These adverse effects can precede overt cardiovascular disease and increase morbidity/mortality.
• Clinical manifestations and organ damage are reversible with timely treatment, underscoring the importance of early diagnosis and management.